Skip to main content
Premium Trial:

Request an Annual Quote

Senate Confirms Lander

The Senate has confirmed Eric Lander to lead the White House Office of Science and Technology Policy in a voice vote, the Hill reports.

President Joe Biden nominated Lander, the director of the Broad Institute, to serve as science advisor, a post he elevated to a Cabinet-level position, in January. NBC News noted at the time that the change was meant to accentuate the Biden Administration's commitment to science.

During his nomination hearing, Lander faced questions about his meetings with financier and sex offender Jeffrey Epstein and his downplaying of the contributions of women in science. Lander said that his interactions with Epstein were brief and that he did not learn of his "sordid history" until later. He, meanwhile, acknowledged that he understated the roles of Jennifer Doudna and Emmanuelle Charpentier in the development of CRISPR and promised to "make full inclusion and equitable outcomes a high priority."

Politico notes, that Lander, who was confirmed Friday, was the last of President Biden's Cabinet nominees to be confirmed. Lander previously served as co-chair of the Presidential Council of Advisers on Science and Technology during the Obama Administration.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.